Molecular Imaging: Page 42

PET/CT reveals different reactions to COVID-19 vaccines

By Will Morton

PET/CT imaging shows that COVID-19 mRNA vaccines appear to cause higher rates of reactive lymph nodes in cancer patients compared with whole-virus vaccines, according to a study presented at the American Roentgen Ray Society meeting in Honolulu.

April 26, 2023

Is special labeling needed for radioactive specimens?

By Will Morton

Special labeling and shipping precautions for radioactive sentinel lymph node (SLN) specimens may not be necessary in hospitals, according to a study published April 21 in the Journal of Medical Imaging and Radiation Science.

April 25, 2023

PET/CT predicts survival in women with inflammatory breast cancer

By Will Morton

PET/CT imaging can improve survival outcomes in women with inflammatory breast cancer when used as an initial staging approach rather than ultrasound, according to a study presented at the American Roentgen Ray Society annual meeting in Hawaii.

April 25, 2023

GE HealthCare posts revenue gains in Q1

By AuntMinnie.com staff writers

GE HealthCare produced double-digit percentage organic growth in first-quarter revenue, as well as adjusted earnings before interest and taxes and earnings per share.

April 24, 2023

Pluvicto manufacturing approved at U.S. facility

By AuntMinnie.com staff writers

Novartis has received U.S. Food and Drug Administration (FDA) approval to begin manufacturing supplies for its prostate cancer drug Pluvicto at its Millburn, NJ, facility.

April 23, 2023

Dynamic digital radiography tested in lung transplant patients

By Will Morton

Dynamic digital radiography (DDR) estimates for measuring blood flow in the lungs matched lung perfusion scintigraphy in a group of lung transplant patients, according to research presented at the American Roentgen Ray Society (ARRS) annual meeting in Honolulu.

April 23, 2023

SNMMI highlights prostate cancer study

By AuntMinnie.com staff writers

A recent study highlighted by the Society for Nuclear Medicine and Molecular Imaging (SNMMI) presents a new PET scoring system for predicting whether prostate cancer patients will respond to treatment with lutetium-177 prostate-specific membrane antigen-617.

April 20, 2023

PET/MRE improves detection of Crohn's disease

By Will Morton

Simultaneous PET/MR enterography (MRE) can improve the detection of active inflammatory Crohn's disease, according to an April 19 presentation at the American Roentgen Ray Society annual meeting in Honolulu.

April 20, 2023

Ionetix produces first At-211 radioisotope at new facility

By AuntMinnie.com staff writers

Cyclotron technology developer Ionetix has produced the first batch of therapeutic radioisotope astatine-211 (At-211) at its new alpha isotope manufacturing facility in Lansing, MI.

April 18, 2023

PET/CT key to imaging patients with prostate cancer

By Will Morton

PET/CT imaging with novel radiotracers has emerged over the past several years as a first-line approach for diagnosing and monitoring treatments in patients with prostate cancer, according to an April 16 presentation at ARRS 2023 in Honolulu, HI.

April 18, 2023

MICI 2023 Q1: Admins remain optimistic about imaging as a profit center

By Kate Madden Yee

Radiology administrators remain positive that diagnostic and interventional radiology will grow as a profit center in 2023, according to MarkeTech Group's first-quarter 2023 Medical Imaging Confidence Index (MICI) report.

April 16, 2023

Racial disparities persist in genitourinary clinical trials

By Will Morton

Racial disparities persist in genitourinary clinical trials of new biologic drugs and PET imaging radiotracers, according to a study published April 13 in Current Problems in Cancer.

April 16, 2023

Previous Page

Page 42 of 612

Next Page